7-phenanthren-2-yl-9-(10-triphenylen-2-ylphenoxazin-3-yl)benzo[c]phenoxazine
C60H36N2O2 — CID 155791009
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-phenanthren-2-yl-9-(10-triphenylen-2-ylphenoxazin-3-yl)benzo[c]phenoxazine
7-phenanthren-2-yl-9-(10-triphenylen-2-ylphenoxazin-3-yl)benzo[c]phenoxazine (PubChem CID 155791009) has the molecular formula C60H36N2O2 and a molecular weight of 816.96 g/mol. Its IUPAC name is 7-phenanthren-2-yl-9-(10-triphenylen-2-ylphenoxazin-3-yl)benzo[c]phenoxazine.
Molecular Properties
| Compound Name | 7-phenanthren-2-yl-9-(10-triphenylen-2-ylphenoxazin-3-yl)benzo[c]phenoxazine |
|---|---|
| PubChem CID | 155791009 |
| Molecular Formula | C60H36N2O2 |
| Molecular Weight | 816.96 g/mol |
| Exact Mass | 816.28 |
| IUPAC Name | 7-phenanthren-2-yl-9-(10-triphenylen-2-ylphenoxazin-3-yl)benzo[c]phenoxazine |
| SMILES | c1ccc2c(c1)Oc1cc(-c3ccc4c(c3)N(c3ccc5c(ccc6ccccc65)c3)c3ccc5ccccc5c3O4)ccc1N2c1ccc2c3ccccc3c3ccccc3c2c1 |
| InChI | InChI=1S/C60H36N2O2/c1-3-13-44-37(11-1)21-22-41-33-42(26-28-45(41)44)62-55-31-23-38-12-2-4-14-46(38)60(55)64-58-32-25-39(34-56(58)62)40-24-30-54-59(35-40)63-57-20-10-9-19-53(57)61(54)43-27-29-51-49-17-6-5-15-47(49)48-16-7-8-18-50(48)52(51)36-43/h1-36H |
| InChIKey | NGDKOJLFBWUZRE-UHFFFAOYSA-N |
| XLogP | 17.42 |
| TPSA | 24.94 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 816.96 |
| LogP ≤ 5 | 17.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155791009 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.